By utilizing the 2-hydroxyisophthalic acid (H 3 ipO) ligand, 2D metal−organic frameworks (MOFs) featuring rare O phenol -bridged [Ln 2 ]magnetic building blocks (MBBs), [Ln 2 (ipO) 2 (DMF)(H 2 O)] [Ln = Gd (1), Dy (2); DMF = N,N-dimethylformamide], were rationally designed and synthesized. When the reaction solvents that behave as terminal ligands were changed, the coordination geometries of Ln III ions and the arrangement fashion of [Ln 2 ]-MBBs for these MOFs were modified accordingly. Another 3), Dy (4)] was thus obtained. MOFs 1 and 3 exhibited favorable magnetocaloric effect, whose maximum −ΔS m values reach 30.0 and 31.7 J kg −1 K −1 , respectively. None of the single-molecule-magnet (SMM) behavior was observed in 2. However, from 2 to 4, the change of the terminal coordinated solvents brought obvious improvement of the magnetic properties. MOF 4 showed interesting relaxation behavior, in which dual relaxation was only visible under weak direct-current fields, and its highest effective energy barrier (U eff ) reached up to 243 K. Ab initio calculations revealed the tuning mechanism of the terminal coordinated solvents. Their change optimized the arrangements of the magnetic axis of the Dy III centers in both each MBB and the whole framework, thus improving the magnetic anisotropy and magnetic interactions of the system. Significantly, within the [Dy 2 ]-MBBs of 4, the angle made by the individual magnetic axis and Dy•••Dy′ line is nearly 0°. This case favoring a high SMM performance not only was scarcely achieved in discrete {Ln 2 }-SMMs with numerous members but also has never been observed in any MBB-based MOFs as far as we know.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.